{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:13:45Z","timestamp":1790522025198,"version":"4.1.0"},"reference-count":86,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"University of Antwerp (Lanceringsproject)"},{"name":"Fund for Scientific Research, Flanders","award":["FWO, Belgium, G.0221.12"],"award-info":[{"award-number":["FWO, Belgium, G.0221.12"]}]},{"name":"The Dutch Heart Foundation","award":["2013T093"],"award-info":[{"award-number":["2013T093"]}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"crossref","award":["MIBAVA - Leducq 12CVD03"],"award-info":[{"award-number":["MIBAVA - Leducq 12CVD03"]}],"id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["ERC- StG-2012-30972-BRAVE"],"award-info":[{"award-number":["ERC- StG-2012-30972-BRAVE"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Mutation"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1002\/humu.22977","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T12:43:01Z","timestamp":1456490581000},"page":"524-531","source":"Crossref","is-referenced-by-count":148,"title":["Marfan Syndrome and Related Disorders: 25 Years of Gene Discovery"],"prefix":"10.1155","volume":"37","author":[{"given":"Aline","family":"Verstraeten","sequence":"first","affiliation":[{"name":"Center of Medical Genetics, Faculty of Medicine and Health Sciences; University of Antwerp and Antwerp University Hospital; Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Alaerts","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, Faculty of Medicine and Health Sciences; University of Antwerp and Antwerp University Hospital; Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lut","family":"Van Laer","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, Faculty of Medicine and Health Sciences; University of Antwerp and Antwerp University Hospital; Antwerp Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Loeys","sequence":"additional","affiliation":[{"name":"Center of Medical Genetics, Faculty of Medicine and Health Sciences; University of Antwerp and Antwerp University Hospital; Antwerp Belgium"},{"name":"Department of Human Genetics; Radboud University Nijmegen Medical Center; Nijmegen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"key":"10.1002\/humu.22977-BIB0001|humu22977-cit-0001","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajmg.a.31202","article-title":"FBN1, TGFBR1, and the Marfan-craniosynostosis\/mental retardation disorders revisited","volume":"140","author":"Ades","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.22977-BIB0002|humu22977-cit-0002","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/hmg\/ddv037","article-title":"The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele","volume":"24","author":"Aubart","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22977-BIB0003|humu22977-cit-0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/gim.2014.91","article-title":"Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events","volume":"17","author":"Baudhuin","year":"2015","journal-title":"Genet Med"},{"key":"10.1002\/humu.22977-BIB0004|humu22977-cit-0004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/hrt.2010.210286","article-title":"Surgical management of aortic root disease in Marfan syndrome: a systematic review and meta-analysis","volume":"97","author":"Benedetto","year":"2011","journal-title":"Heart"},{"key":"10.1002\/humu.22977-BIB0005|humu22977-cit-0005","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/thx.23.4.338","article-title":"A technique for complete replacement of the ascending aorta","volume":"23","author":"Bentall","year":"1968","journal-title":"Thorax"},{"key":"10.1002\/humu.22977-BIB0006|humu22977-cit-0006","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2015.01.040","article-title":"Mutations in a TGF-beta ligand, TGFB3, cause syndromic aortic aneurysms and dissections","volume":"65","author":"Bertoli-Avella","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1002\/humu.22977-BIB0007|humu22977-cit-0007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1358863X15569868","article-title":"Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome","volume":"20","author":"Bhatt","year":"2015","journal-title":"Vasc Med"},{"key":"10.1002\/humu.22977-BIB0008|humu22977-cit-0008","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/ng.2348","article-title":"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome","volume":"44","author":"Boileau","year":"2012","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0009|humu22977-cit-0009","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MOP.0b013e3283557d4c","article-title":"Marfan syndrome: from gene to therapy","volume":"24","author":"Bolar","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1002\/humu.22977-BIB0010|humu22977-cit-0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cjca.2015.11.007","article-title":"The expanding clinical spectrum of extracardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysm and dissection","volume":"32","author":"Bradley","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1002\/humu.22977-BIB0011|humu22977-cit-0011","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22977-BIB0012|humu22977-cit-0012","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/ajmg.a.34015","article-title":"TGFBR2 deletion in a 20-month-old female with developmental delay and microcephaly","volume":"155A","author":"Campbell","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"12","key":"10.1002\/humu.22977-BIB0013|humu22977-cit-0013","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ejmg.2015.10.010","article-title":"TGF-beta signalopathies as a paradigm for translational medicine","volume":"58","author":"Cannaerts","year":"2015","journal-title":"Eur J Med Genet"},{"key":"10.1002\/humu.22977-BIB0014|humu22977-cit-0014","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ajhg.2012.10.002","article-title":"In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome","volume":"91","author":"Carmignac","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22977-BIB0015|humu22977-cit-0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1002\/humu.22977-BIB0016|humu22977-cit-0016","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat Med"},{"key":"10.1002\/humu.22977-BIB0017|humu22977-cit-0017","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-8166-5-5","article-title":"Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene","volume":"5","author":"Colovati","year":"2012","journal-title":"Mol Cytogenet"},{"key":"10.1002\/humu.22977-BIB0018|humu22977-cit-0018","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cge.12436","article-title":"Cardiovascular manifestations in Marfan syndrome and related diseases; multiple genes causing similar phenotypes","volume":"87","author":"Cook","year":"2015","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22977-BIB0019|humu22977-cit-0019","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1002\/humu.22977-BIB0020|humu22977-cit-0020","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/geno.1993.1349","article-title":"Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome","volume":"17","author":"Dietz","year":"1993","journal-title":"Genomics"},{"key":"10.1002\/humu.22977-BIB0021|humu22977-cit-0021","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ng.2421","article-title":"Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm","volume":"44","author":"Doyle","year":"2012","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0022|humu22977-cit-0022","doi-asserted-by":"crossref","first-page":"e08648","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1002\/humu.22977-BIB0023|humu22977-cit-0023","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0003-4975(97)00061-1","article-title":"Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome","volume":"63","author":"Fleischer","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/humu.22977-BIB0024|humu22977-cit-0024","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","author":"Forteza","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1002\/humu.22977-BIB0025|humu22977-cit-0025","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome","volume":"168","author":"Franken","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1002\/humu.22977-BIB0026|humu22977-cit-0026","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1002\/humu.22977-BIB0027|humu22977-cit-0027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(93)90489-D","article-title":"Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor","volume":"75","author":"Franzen","year":"1993","journal-title":"Cell"},{"key":"10.1002\/humu.22977-BIB0028|humu22977-cit-0028","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI69666","article-title":"Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis","volume":"124","author":"Gallo","year":"2014","journal-title":"J Clin Investig"},{"key":"10.1002\/humu.22977-BIB0029|humu22977-cit-0029","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1111\/j.1651-2227.2011.02293.x","article-title":"The effect of beta-blocker therapy on progressive aortic dilatation in children and adolescents with Marfan's syndrome: a meta-analysis","volume":"100","author":"Gao","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1002\/humu.22977-BIB0030|humu22977-cit-0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2005.11.116","article-title":"The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis","volume":"114","author":"Gersony","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1002\/humu.22977-BIB0031|humu22977-cit-0031","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCRESAHA.113.300675","article-title":"Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility","volume":"113","author":"Gillis","year":"2013","journal-title":"Circ Res"},{"key":"10.1002\/humu.22977-BIB0032|humu22977-cit-0032","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jama.1989.03430040095032","article-title":"Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum","volume":"262","author":"Glesby","year":"1989","journal-title":"JAMA"},{"key":"10.1002\/humu.22977-BIB0033|humu22977-cit-0033","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM199904293401702","article-title":"Replacement of the aortic root in patients with Marfan's syndrome","volume":"340","author":"Gott","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22977-BIB0034|humu22977-cit-0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng.780","article-title":"Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1","volume":"43","author":"Goudie","year":"2011","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0035|humu22977-cit-0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S","article-title":"Shprintzen-Goldberg syndrome: a clinical analysis","volume":"76","author":"Greally","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1002\/humu.22977-BIB0036|humu22977-cit-0036","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1002\/humu.22977-BIB0037|humu22977-cit-0037","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<280::AID-HUMU3>3.0.CO;2-L","article-title":"Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: report of 12 novel mutations","volume":"10","author":"Hayward","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22977-BIB0038|humu22977-cit-0038","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/cge.12073","article-title":"Homozygosity for a FBN1 missense mutation causes a severe Marfan syndrome phenotype","volume":"84","author":"Hogue","year":"2013","journal-title":"Clin Genet"},{"key":"10.1002\/humu.22977-BIB0039|humu22977-cit-0039","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1002\/humu.22977-BIB0040|humu22977-cit-0040","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1242\/jcs.074773","article-title":"Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity","volume":"123","author":"Horbelt","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1002\/humu.22977-BIB0041|humu22977-cit-0041","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/hmg\/ddg241","article-title":"Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype","volume":"12","author":"Hutchinson","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.22977-BIB0042|humu22977-cit-0042","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1074\/jbc.M209256200","article-title":"Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein","volume":"278","author":"Isogai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22977-BIB0043|humu22977-cit-0043","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1242\/dev.00708","article-title":"Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects","volume":"130","author":"Ito","year":"2003","journal-title":"Development"},{"key":"10.1002\/humu.22977-BIB0044|humu22977-cit-0044","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1002\/humu.22977-BIB0045|humu22977-cit-0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajmg.a.31006","article-title":"Molecular pathology of Shprintzen-Goldberg syndrome","volume":"140","author":"Kosaki","year":"2006","journal-title":"Am J Med Genet A"},{"key":"10.1002\/humu.22977-BIB0046|humu22977-cit-0046","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.mcp.2015.07.003","article-title":"Exome sequencing identifies a novel heterozygous TGFB3 mutation in a disorder overlapping with Marfan and Loeys-Dietz syndrome","volume":"29","author":"Kuechler","year":"2015","journal-title":"Mol Cell Probes"},{"key":"10.1002\/humu.22977-BIB0047|humu22977-cit-0047","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Medi"},{"key":"10.1002\/humu.22977-BIB0048|humu22977-cit-0048","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjcard.2006.08.048","article-title":"Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome","volume":"99","author":"Ladouceur","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1002\/humu.22977-BIB0049|humu22977-cit-0049","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/01.hjh.0000182521.44440.c5","article-title":"Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats","volume":"23","author":"Lavoie","year":"2005","journal-title":"J Hypertens"},{"key":"10.1002\/humu.22977-BIB0050|humu22977-cit-0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"10.1002\/humu.22977-BIB0051|humu22977-cit-0051","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature10145","article-title":"Lessons on the pathogenesis of aneurysm from heritable conditions","volume":"473","author":"Lindsay","year":"2011","journal-title":"Nature"},{"key":"10.1002\/humu.22977-BIB0052|humu22977-cit-0052","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ng.2349","article-title":"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm","volume":"44","author":"Lindsay","year":"2012","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0053|humu22977-cit-0053","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0054|humu22977-cit-0054","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"10.1002\/humu.22977-BIB0055|humu22977-cit-0055","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22977-BIB0056|humu22977-cit-0056","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1101\/gad.13.17.2196","article-title":"The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling","volume":"13","author":"Luo","year":"1999","journal-title":"Genes Dev"},{"key":"10.1002\/humu.22977-BIB0057|humu22977-cit-0057","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/gim.2014.11","article-title":"Loeys-Dietz syndrome: a primer for diagnosis and management","volume":"16","author":"Maccarrick","year":"2014","journal-title":"Genet Med"},{"key":"10.1002\/humu.22977-BIB0058|humu22977-cit-0058","first-page":"220","article-title":"Un cas de d\u00e9formation cong\u00e9nitale des quatres membres, plus prononc\u00e9e aux extremit\u00e9s, caract\u00e9ris\u00e9e par l'allongement des os avec un certain degr\u00e9 d'amincissement","volume":"13","author":"Marfan","year":"1896","journal-title":"Bulletins et memoires de la Soci\u00e9t\u00e9 medicale des H\u00f4pitaux de Paris"},{"key":"10.1002\/humu.22977-BIB0059|humu22977-cit-0059","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-007-0371-x","article-title":"Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome","volume":"122","author":"Matyas","year":"2007","journal-title":"Hum Genet"},{"key":"10.1002\/humu.22977-BIB0060|humu22977-cit-0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.11.3.321","article-title":"The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue","volume":"11","author":"McKusick","year":"1955","journal-title":"Circulation"},{"key":"10.1002\/humu.22977-BIB0061|humu22977-cit-0061","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/humu.22854","article-title":"SMAD2 mutations are associated with arterial aneurysms and dissections","volume":"36","author":"Micha","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.22977-BIB0062|humu22977-cit-0062","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1002\/humu.22977-BIB0063|humu22977-cit-0063","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ng1392","article-title":"Heterozygous TGFBR2 mutations in Marfan syndrome","volume":"36","author":"Mizuguchi","year":"2004","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0064|humu22977-cit-0064","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0065|humu22977-cit-0065","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1002\/humu.22977-BIB0066|humu22977-cit-0066","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","volume":"112","author":"Pees","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1002\/humu.22977-BIB0067|humu22977-cit-0067","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1097-218","article-title":"Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome","volume":"17","author":"Pereira","year":"1997","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0068|humu22977-cit-0068","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","article-title":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan treatment Trialists' collaboration","volume":"169","author":"Pitcher","year":"2015","journal-title":"Am Heart J"},{"key":"10.1002\/humu.22977-BIB0069|humu22977-cit-0069","doi-asserted-by":"crossref","first-page":"26249","DOI":"10.1074\/jbc.M304459200","article-title":"The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation","volume":"278","author":"Prunier","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.22977-BIB0070|humu22977-cit-0070","doi-asserted-by":"crossref","first-page":"e89749","DOI":"10.1371\/journal.pone.0089749","article-title":"Absence of cardiovascular manifestations in a haploinsufficient Tgfbr1 mouse model","volume":"9","author":"Renard","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/humu.22977-BIB0071|humu22977-cit-0071","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12881-014-0091-8","article-title":"Further delineation of Loeys-Dietz syndrome type 4 in a family with mild vascular involvement and a TGFB2 splicing mutation","volume":"15","author":"Ritelli","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1002\/humu.22977-BIB0072|humu22977-cit-0072","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1242\/dev.124.13.2659","article-title":"TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes","volume":"124","author":"Sanford","year":"1997","journal-title":"Development"},{"key":"10.1002\/humu.22977-BIB0073|humu22977-cit-0073","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ejhg.2014.61","article-title":"The SMAD-binding domain of SKI: a hotspot for de novo mutations causing Shprintzen-Goldberg syndrome","volume":"23","author":"Schepers","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.22977-BIB0074|humu22977-cit-0074","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/302582","article-title":"Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes","volume":"65","author":"Schrijver","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1002\/humu.22977-BIB0075|humu22977-cit-0075","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/humu.22977-BIB0076|humu22977-cit-0076","first-page":"65","article-title":"A recurrent pattern syndrome of craniosynostosis associated with arachnodactyly and abdominal hernias","volume":"2","author":"Shprintzen","year":"1982","journal-title":"J Craniofac Genet Dev Biol"},{"key":"10.1002\/humu.22977-BIB0077|humu22977-cit-0077","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ng0296-209","article-title":"Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome","volume":"12","author":"Sood","year":"1996","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0078|humu22977-cit-0078","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.ejhg.5200582","article-title":"Classic, atypically severe and neonatal Marfan syndrome: twelve mutations and genotype-phenotype correlations in FBN1 exons 24-40","volume":"9","author":"Tiecke","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1002\/humu.22977-BIB0079|humu22977-cit-0079","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0974-2069.43885","article-title":"Role of beta-blockers in Marfan's syndrome and bicuspid aortic valve: a time for re-appraisal","volume":"1","author":"Vaidyanathan","year":"2008","journal-title":"Ann Pediatr Cardiol"},{"key":"10.1002\/humu.22977-BIB0080|humu22977-cit-0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ng.744","article-title":"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis","volume":"43","author":"de Laar","year":"2011","journal-title":"Nat Genet"},{"key":"10.1002\/humu.22977-BIB0081|humu22977-cit-0081","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","article-title":"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome","volume":"49","author":"de Laar","year":"2012","journal-title":"J Med Genet"},{"key":"10.1002\/humu.22977-BIB0082|humu22977-cit-0082","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/HCO.0b013e32833f0220","article-title":"The Loeys-Dietz syndrome: an update for the clinician","volume":"25","author":"Hemelrijk","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"10.1002\/humu.22977-BIB0083|humu22977-cit-0083","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/hrt.2006.109454","article-title":"Medical treatment of Marfan syndrome: a time for change","volume":"94","author":"Williams","year":"2008","journal-title":"Heart"},{"key":"10.1002\/humu.22977-BIB0084|humu22977-cit-0084","doi-asserted-by":"crossref","first-page":"S757","DOI":"10.1016\/j.athoracsur.2006.10.091","article-title":"Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease","volume":"83","author":"Williams","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1002\/humu.22977-BIB0085|humu22977-cit-0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1002\/humu.22977-BIB0086|humu22977-cit-0086","first-page":"968135","article-title":"A novel mutation of SMAD3 identified in a Chinese family with Aneurysms-Osteoarthritis syndrome","volume":"2015","author":"Zhang","year":"2015","journal-title":"Biomed Res Int"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.22977","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/humu.22977\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T16:54:13Z","timestamp":1672332853000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.22977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/humu.22977","archive":["Portico"],"relation":{},"ISSN":["1059-7794"],"issn-type":[{"value":"1059-7794","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3,14]]}}}